BUSINESS

Shoichiro Ogawa Tapped as Alcon Pharma Japan Chief

October 3, 2017

- Only subscribers can save articles.
  
  Sign In
  
  Subscribe

Alcon Pharma appointed Shoichiro Ogawa as its president effective October 1, the company, which was created in April through the integration of Novartis Pharma’s ophthalmology division and Alcon Japan’s pharma unit, said on October 2. Mr Ogawa, 48, assumed the…

To read the full story

Alcon Pharma to Be Integrated into Novartis Japan in April
March 6, 2019
Alcon Pharma Kicks Off Operations
April 3, 2017

BUSINESS

Positive Price Revisions Seen at Several Firms in FY2026 Reform: Poll
March 6, 2026
Sawai Pharmaceutical to Promote Toshiomi Nakate to President
March 6, 2026
Asahi Kasei Pharma to Rebrand as Asahi Kasei Therapeutics in April
March 6, 2026
Keytruda Maintains Top Spot for 29 Straight Months in February: Encise
March 6, 2026
Takeda Files Japan NDA for Narcolepsy Drug Oveporexton
March 5, 2026

Chuikyo Debate on FY2026 Drug Pricing Reform

Chuikyo OKs New CEA Handling, with Third-Party Verification Ahead

Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…

COMMENTARY

G1 Rule to Hit Originator Biologics for First Time, Impact Seen for Up to 13 Brands

By Shinya Sato

Japan’s FY2026 drug pricing reform will, for the first time, apply the “G1” price cut rule for long-listed original biologics…

COLUMN

The Strategic MSL: Beyond Data Delivery, It’s About Impact

By Philip Carrigan

I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…